Golden State Wealth Management, LLC

Position in ABBV — AbbVie Inc.

CIK 1776033 SANTA ANA, CA

Position in ABBV

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$691,255

+$101,858 QoQ

Shares Held

2,747

+1.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#2,882

of 4,153 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Golden State Wealth Management, LLC holds $5,982,098 across 14 Drug Manufacturers - General names. ABBV ranks #4 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,159	$1,390,139
2	JNJ	Johnson & Johnson	4,761	$1,209,151
3	MRK	Merck & Co., Inc.	6,790	$872,515
4	ABBV	AbbVie Inc. This page	2,747	$691,255
5	AMGN	Amgen Inc	1,814	$656,885
6	PFE	Pfizer Inc	11,293	$271,935
7	AZN	Astrazeneca PLC	1,109	$210,288
8	BMY	Bristol Myers Squibb Co	3,040	$175,164

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$691,255	2,747	+1.4%	Shares	Sole	2026-07-22
2026-03-31	$589,397	2,710	+9.1%	Shares	Sole	2026-04-28
2025-12-31	$567,797	2,485	-5.7%	Shares	Sole	2026-02-13
2025-09-30	$610,107	2,635	+0.3%	Shares	Sole	2025-11-03
2025-06-30	$487,623	2,627	+23.7%	Shares	Sole	2025-08-06
2025-03-31	$445,020	2,124	+4.6%	Shares	Sole	2025-04-24
2024-12-31	$360,908	2,031	-42.0%	Shares	Sole	2025-01-28
2022-03-31	$568,033	3,504	-66.0%	Shares	Sole	2022-05-19
2021-12-31	$1,393,672	10,293	+116.8%	Shares	Sole	2022-02-14
2021-09-30	$512,166	4,748	-2.2%	Shares	Sole	2021-11-15
2021-06-30	$546,754	4,854	-5.3%	Shares	Sole	2021-08-12
2021-03-31	$554,627	5,125	-55.8%	Shares	Sole	2021-05-14
2020-12-31	$1,242,618	11,597	-5.6%	Shares	Sole	2021-01-28
2020-09-30	$1,075,955	12,284	-11.7%	Shares	Sole	2020-11-12
2020-06-30	$1,365,978	13,913	+39.2%	Shares	Sole	2020-08-13
2020-03-31	$761,595	9,996	—	Shares	Sole	2020-04-17
No filing history on record for this holder in this stock.